Adaptimmune Therapeutics PLC Depreciation in USD from 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Depreciation history and growth rate from 2013 to Q1 2025.
  • Adaptimmune Therapeutics PLC Depreciation for the quarter ending March 31, 2025 was $2.29M, a 17.3% decline year-over-year.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2024 was $10.8M, a 14.4% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2023 was $9.45M, a 79.5% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2022 was $5.27M, a 6.47% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Adaptimmune Therapeutics PLC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $2.29M -$480K -17.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $2.77M +$1.11M +67% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $1.66M +$273K +19.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $1.39M -$50K -3.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $1.44M -$275K -16.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $1.71M -$117K -6.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $1.83M +$88K +5.06% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $5.79M $1.74M +$754K +76.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $5.03M $1.61M +$778K +93.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $4.25M $1.4M +$616K +79.1% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $3.64M $1.04M +$233K +29% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $3.41M $986K +$279K +39.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $3.13M $836K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $779K +$316K +68.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $804K +$507K +171% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $707K +$639K +940% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $463K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $297K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $68K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12

Adaptimmune Therapeutics PLC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10.8M +$1.36M +14.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $9.45M +$4.19M +79.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $5.27M -$364K -6.47% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-24
2021 $5.63M -$997K -15% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $6.63M -$545K -7.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $7.17M -$16K -0.22% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $7.19M +$2.16M +42.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $5.03M +$1.91M +61% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $3.13M +$2.42M +343% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $705K +$465K +194% Jul 1, 2014 Jun 30, 2015 10-K 2018-03-15
2014 $240K +$193K +411% Jul 1, 2013 Jun 30, 2014 10-K 2017-03-13
2013 $47K Jul 1, 2012 Jun 30, 2013 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.